Canesten antifungal treatment

Canesten is a globally recognized brand specializing in antifungal treatments, particularly known for its active ingredient Clotrimazole. The brand was originally developed in Germany by the pharmaceutical giant Bayer, which first synthesized Clotrimazole in the late 1960s.

Today, Canesten remains one of Bayer's most prominent consumer health brands. Production occurs in various specialized pharmaceutical facilities across the globe, including major manufacturing hubs in Germany, the United Kingdom, and Italy, to meet international demand for skin and intimate health care. Ownership remains firmly with Bayer AG, a multinational life sciences company headquartered in Leverkusen, Germany.